203 related articles for article (PubMed ID: 17607668)
1. Cost effectiveness of mammography screening for Chinese women.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
[No Abstract] [Full Text] [Related]
3. Using Risk Stratification to Optimize Mammography Screening in Chinese Women.
Leung K; Wu JT; Wong IO; Shu XO; Zheng W; Wen W; Khoo US; Ngan R; Kwong A; Leung GM
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377936
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
Salzmann P; Kerlikowske K; Phillips K
Ann Intern Med; 1997 Dec; 127(11):955-65. PubMed ID: 9412300
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
[TBL] [Abstract][Full Text] [Related]
10. Cost-effective mammography screening in Korea: high incidence of breast cancer in young women.
Lee SY; Jeong SH; Kim YN; Kim J; Kang DR; Kim HC; Nam CM
Cancer Sci; 2009 Jun; 100(6):1105-11. PubMed ID: 19320639
[TBL] [Abstract][Full Text] [Related]
11. Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women.
Wong IO; Tsang JW; Cowling BJ; Leung GM
Cancer; 2012 Sep; 118(18):4394-403. PubMed ID: 22359352
[TBL] [Abstract][Full Text] [Related]
12. Retrospective cost-effectiveness analysis of screening mammography.
Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of risk-based breast cancer screening programme, China.
Sun L; Legood R; Sadique Z; Dos-Santos-Silva I; Yang L
Bull World Health Organ; 2018 Aug; 96(8):568-577. PubMed ID: 30104797
[TBL] [Abstract][Full Text] [Related]
14. What is the most cost-effective population-based cancer screening program for Chinese women?
Woo PP; Kim JJ; Leung GM
J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
[TBL] [Abstract][Full Text] [Related]
16. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Kerlikowske K; Salzmann P; Phillips KA; Cauley JA; Cummings SR
JAMA; 1999 Dec; 282(22):2156-63. PubMed ID: 10591338
[TBL] [Abstract][Full Text] [Related]
17. Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.
Shih YT; Dong W; Xu Y; Etzioni R; Shen Y
Ann Intern Med; 2021 May; 174(5):602-612. PubMed ID: 33556275
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness of an organized breast cancer screening program in Southern Brazil].
Ribeiro RA; Caleffi M; Polanczyk CA
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S131-45. PubMed ID: 25402242
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]